These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16981980)

  • 61. Comparison of subcutaneous and transdermal administration of buprenorphine for pre-emptive analgesia in dogs undergoing elective ovariohysterectomy.
    Moll X; Fresno L; García F; Prandi D; Andaluz A
    Vet J; 2011 Jan; 187(1):124-8. PubMed ID: 20056555
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Transdermal buprenorphine: a current overview of pharmacological and clinical data].
    Faymonville ME; Libbrecht D
    Rev Med Liege; 2008 Nov; 63(11):671-6. PubMed ID: 19112993
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The use of transdermal buprenorphine to relieve radiotherapy-related pain in head and neck cancer patients.
    Menten J; Carpentier I; Deschutter H; Nuyts S; Van Beek K
    Cancer Invest; 2013 Jul; 31(6):412-20. PubMed ID: 23758187
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transdermal buprenorphine in clinical practice: results from a multicenter, noninterventional postmarketing study in Slovenia.
    Skvarc NK
    Pain Manag; 2012 Mar; 2(2):177-83. PubMed ID: 24645820
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transdermal buprenorphine for the treatment of chronic noncancer pain in the oldest old.
    Gianni W; Madaio AR; Ceci M; Benincasa E; Conati G; Franchi F; Galetti G; Nieddu A; Salani B; Zuccaro SM
    J Pain Symptom Manage; 2011 Apr; 41(4):707-14. PubMed ID: 21145700
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Retrospective analysis of 4 years of clinical experience with transdermal buprenorphine (Transtec) in post-traumatic pain.
    Correa-Illanes G; Roa RG; B Piñeros JL; Ferrer FT; Adriasola VR
    Pain Manag; 2014 May; 4(3):181-90. PubMed ID: 24835268
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Transdermal buprenorphine.
    Evans HC; Easthope SE
    Drugs; 2003; 63(19):1999-2010; discussion 2011-2. PubMed ID: 12962515
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plasma buprenorphine concentrations after the application of a 70 microg/h transdermal patch in dogs. Preliminary report.
    Andaluz A; Moll X; Ventura R; Abellán R; Fresno L; García F
    J Vet Pharmacol Ther; 2009 Oct; 32(5):503-5. PubMed ID: 19754919
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain].
    Likar R; Griessinger N; Sadjak A; Sittl R
    Wien Med Wochenschr; 2003; 153(13-14):317-22. PubMed ID: 12924108
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany.
    Greiner W; Lehmann K; Earnshaw S; Bug C; Sabatowski R
    Eur J Health Econ; 2006 Dec; 7(4):290-6. PubMed ID: 16983521
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Transdermal buprenorphine during pregnancy].
    Ebner E; Wiedmann M
    Schmerz; 2006 Aug; 20(4):334-7. PubMed ID: 16283207
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pain management in palliative cancer patients: a prospective observational study on the use of high dosages of transdermal buprenorphine.
    Clement PM; Beuselinck B; Mertens PG; Cornelissen P; Menten J
    Acta Clin Belg; 2013; 68(2):87-91. PubMed ID: 23967714
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intravenous naloxone plus transdermal buprenorphine in cancer pain associated with intractable cholestatic pruritus.
    Marinangeli F; Guetti C; Angeletti C; Bonetti C; Paladini A; Piroli A; Varrassi G
    J Pain Symptom Manage; 2009 Oct; 38(4):e5-8. PubMed ID: 19699606
    [No Abstract]   [Full Text] [Related]  

  • 74. Current practices for postoperative pain management in Europe and the potential role of the fentanyl HCl iontophoretic transdermal system.
    Rawal N; Langford RM
    Eur J Anaesthesiol; 2007 Apr; 24(4):299-308. PubMed ID: 17156510
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A successful switch from transdermal fentanyl to transdermal buprenorphine in a patient with neuropathic pain: a case report.
    Leppert W
    Am J Hosp Palliat Care; 2014 Feb; 31(1):101-4. PubMed ID: 23349342
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transdermal buprenorphine for treating nociceptive and neuropathic pain: four case studies.
    Likar R; Sittl R
    Anesth Analg; 2005 Mar; 100(3):781-785. PubMed ID: 15728068
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Buprenorphine matrix patch well tolerated. The challenge of tumor pain].
    MMW Fortschr Med; 2006 Jan; 148(1-2):42-3. PubMed ID: 16612846
    [No Abstract]   [Full Text] [Related]  

  • 78. Buprenorphine maintenance therapy hinders acute pain management in trauma.
    Harrington CJ; Zaydfudim V
    Am Surg; 2010 Apr; 76(4):397-9. PubMed ID: 20420250
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Assessment of analgesic effects of different initial doses of transdermal buprenorphine in the treatment of chronic pain in the elderly diagnosed with osteoarthritis.
    Widenka M; Leppert W
    J Physiol Pharmacol; 2020 Oct; 71(5):. PubMed ID: 33571966
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Once-weekly transdermal buprenorphine application results in sustained and consistent steady-state plasma levels.
    Kapil RP; Cipriano A; Friedman K; Michels G; Shet MS; Colucci SV; Apseloff G; Kitzmiller J; Harris SC
    J Pain Symptom Manage; 2013 Jul; 46(1):65-75. PubMed ID: 23026548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.